But why mid 20's ? So we read into Crosby sale, we read into...

But why mid 20's ? So we read into Crosby sale, we read into slow implant rate. Whilst this is not good news, is it really that bad that we see the market cap and SP down to what it is? I dont think so. If the ventrassist had mechanical issue problems etc I could understand the risk. Commercialisation is here..FDA approval on DT is slow, we already knew this was going to be the case last year at 1.20 per share. This is not an ERG or a MST ...this is a product the World needs and competitors are years behind.
There may even be another capital raising, but will this be discounted from 32 cents, or at a much higher SP? I am buying ..yes I am in the red on this one too, but my average is down to 60cents now...may average down to 45 cents, then putem in the bottom drawer.